» Articles » PMID: 24882343

Applications for Breast Magnetic Resonance Imaging

Overview
Date 2014 Jun 3
PMID 24882343
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

This article reviews the relevant data on breast magnetic resonance imaging (MRI) use in screening, the short-term surgical outcomes and long-term cancer outcomes associated with the use of MRI in breast cancer staging, the use of MRI in occult primary breast cancer, as well as MRI to assess eligibility for accelerated partial breast irradiation and to evaluate tumor response after neoadjuvant chemotherapy. MRI for screening is supported in specific high-risk populations, namely, women with BRCA1 or BRCA2 mutations, a family history suggesting a hereditary breast cancer syndrome, or a history of chest wall radiation.

Citing Articles

Multiregional Radiomic Signatures Based on Functional Parametric Maps from DCE-MRI for Preoperative Identification of Estrogen Receptor and Progesterone Receptor Status in Breast Cancer.

Zhong S, Wang F, Wang Z, Zhou M, Li C, Yin J Diagnostics (Basel). 2022; 12(10).

PMID: 36292247 PMC: 9601361. DOI: 10.3390/diagnostics12102558.


Guidelines for breast cancer management in Bosnia and Herzegovina.

Hadzikadic-Gusic L, Ceric T, Marijanovic I, Iljazovic E, Kopric D, Zorlak A Biomol Biomed. 2022; 23(1):2-14.

PMID: 35880400 PMC: 9901905. DOI: 10.17305/bjbms.2022.7504.


Radiomic nomogram for prediction of axillary lymph node metastasis in breast cancer.

Han L, Zhu Y, Liu Z, Yu T, He C, Jiang W Eur Radiol. 2019; 29(7):3820-3829.

PMID: 30701328 DOI: 10.1007/s00330-018-5981-2.


Measures of Appropriateness and Value for Breast Surgeons and Their Patients: The American Society of Breast Surgeons Choosing Wisely (®) Initiative.

Landercasper J, Bailey L, Berry T, Buras R, Degnim A, Fayanju O Ann Surg Oncol. 2016; 23(10):3112-8.

PMID: 27334216 PMC: 4999471. DOI: 10.1245/s10434-016-5327-8.


Ultrasonographic findings of triple-negative breast cancer.

Du H, Lin B, Huang D Int J Clin Exp Med. 2015; 8(6):10040-3.

PMID: 26309697 PMC: 4538191.